Vatseba and colleagues observed that in collected PBMCs the highest level of p70S6K1 phosphorylation was determined in the T2DM group, while an unexpected result of reduction of p70S6K1 phosphorylation was noticed in postmenopausal T2DM patients diagnosed with cancer [226]. The gene discussed is RPS6KB1; the disease is cancer.